Vor Biopharma VOR
NASDAQ VOR
$18.26 -0.68 (-3.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vor Biopharma (VOR) Cash & Current Investments (2020 - 2026)

Updated

Vor Biopharma (VOR) recorded Cash & Current Investments of $466.13 million in Q2 2026, up 132.4% from $200.57 million a year earlier but down 5.2% from the prior quarter.

Analysis

Vor Biopharma (VOR) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Vor Biopharma reported Cash & Current Investments of $455.21 million, up 395.2% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 56.5% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $91.93 million in FY2024 (-33.0%), $137.18 million in FY2023 (-40.4%), $230.25 million in FY2022 (+11.0%) and $207.47 million in FY2021 (+327.4%).
  • Quarterly Cash & Current Investments has ranged from $60.04 million in Q1 2025 to $491.53 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for five consecutive quarters, with growth averaging 176.7% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 718.7% in Q1 2026, against a decline of 60.8% in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $491.53 million (Q1 2026), $455.21 million (Q4 2025) and $170.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Vor Biopharma 994.36 Mn -588.96 Mn - 466.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 466.13 Mn
Mar 31, 2026 491.53 Mn
Dec 31, 2025 455.21 Mn
Sep 30, 2025 170.46 Mn
Jun 30, 2025 200.57 Mn
Mar 31, 2025 60.04 Mn
Dec 31, 2024 91.93 Mn
Sep 30, 2024 62.81 Mn
Jun 30, 2024 85.94 Mn
Mar 31, 2024 107.48 Mn
Dec 31, 2023 137.18 Mn
Sep 30, 2023 160.10 Mn
Jun 30, 2023 186.90 Mn
Mar 31, 2023 210.20 Mn
Dec 31, 2022 230.25 Mn
Sep 30, 2022 136.07 Mn
Jun 30, 2022 151.09 Mn
Mar 31, 2022 181.62 Mn
Dec 31, 2021 207.47 Mn
Sep 30, 2021 225.97 Mn
API Access

Vor Biopharma Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VOR&period=max&api_key=YOUR_API_KEY